Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q1 2021 · 10-Q
Revenue$24.64M$24.64M+230.1% vs Q1 2020 Net Income$4.22M$4.22MN/M vs Q1 2020 EPS Diluted$0.01$0.01N/M vs Q1 2020 Gross Profit$13,186,000+170.9% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flow$6,759,000N/M Free Cash Flowderived$4,451,000N/M Margins · derivedGross margin53.5%−11.7 pt vs Q1 2020
Operating margin28.6%+15.1 pt vs Q1 2020
Net margin17.1%+49.6 pt vs Q1 2020
ended Mar 31, 2021 · filed May 17, 2021 · 47 d after period end